Table 1.
Subjects | Tot | M/F | Age at MRI (y; Mean ± SD) | Age at Onset (y; Mean ± SD) | Disease Duration at the Time of MRI (m; Mean ± SD) | ALSFRS-R (Mean ± SD) | Phenotype at Onset | |||
---|---|---|---|---|---|---|---|---|---|---|
Prevalent UMN | Bulbar | Classic | Prevalent LMN | |||||||
Patients * | 93 | 55/38 | 62.8 ± 10.1 | 60.8 ± 10.7 | 25 ± 31 | 40.4 ± 6.2 | 14 (15%) | 14 (15%) | 47 (50.5%) | 18 (19.5%) |
Controls | 89 | 56/33 | 60.2 ± 9.5 | / | / | / | / | / | / | / |
p = 0.6 (χ2-test) | p = 0.08 (t-test) | / | / | / | / | / | / | / |
* 12 patients had a mutation (6 had an SOD1 mutation, 5 had a C9ORF72 mutation, and 1 had a TDP43 mutation). M, male; F, female; y, years; m, months; SD = standard deviation; ALSFR-R, revised ALS Functional Rating Scale; UMN, upper motor neuron; LMN, lower motor neuron; MRI, Magnetic Resonance Imaging.